Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith Y Smith

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Research Involvement and Engagement|April 7, 2023
Patients as research partners in preference studies: learnings from IMI-PREFERMeredith Y Smith, Rosanne Janssens, A Cecilia Jimenez-Moreno, et al.
Patient Preference and Adherence|December 1, 2021
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable PopulationSerena Oliveri, Lucilla Lanzoni, Serena Petrocchi, et al.
Frontiers in Pharmacology|October 11, 2021
Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and ItalyRosanne Janssens, Reinhard Arnou, Elise Schoefs, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2020
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studiesChristine A Radawski, Tarek A Hammad, Susan Colilla, et al.
Frontiers in Pharmacology|March 22, 2021
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient PreferencesSerena Petrocchi, Rosanne Janssens, Serena Oliveri, et al.
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
Frontiers in Psychology|July 10, 2023
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternativesSerena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, et al.
Frontiers in Medicine|August 19, 2021
Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing WeightingDario Monzani, Serena Petrocchi, Serena Oliveri, et al.
Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Research Involvement and Engagement|April 7, 2023
Patients as research partners in preference studies: learnings from IMI-PREFERMeredith Y Smith, Rosanne Janssens, A Cecilia Jimenez-Moreno, et al.
Patient Preference and Adherence|December 1, 2021
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable PopulationSerena Oliveri, Lucilla Lanzoni, Serena Petrocchi, et al.
Frontiers in Pharmacology|October 11, 2021
Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and ItalyRosanne Janssens, Reinhard Arnou, Elise Schoefs, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2020
The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studiesChristine A Radawski, Tarek A Hammad, Susan Colilla, et al.
Frontiers in Pharmacology|March 22, 2021
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient PreferencesSerena Petrocchi, Rosanne Janssens, Serena Oliveri, et al.
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.
BMJ Open|February 26, 2026
Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping reviewTheodora Oikonomidi, Hanaya Raad, John Diaz-Decaro, et al.
Frontiers in Psychology|July 10, 2023
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternativesSerena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, et al.
Frontiers in Medicine|August 19, 2021
Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing WeightingDario Monzani, Serena Petrocchi, Serena Oliveri, et al.
Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.
Pageof 5